Author

Anusara Daenthanasanmak

Observed name: Daenthanasanmak, Anusara

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research

Observed institutions: National Institutes of Health, Medical University of South Carolina, University of South Carolina, Stockholm University, Medizinische Hochschule Hannover, MUSC Hollings Cancer Center, National Cancer Institute, Center for Cancer Research, Research Center for Translational Regenerative Medicine

ORCID: 0000-0002-6404-7444

Observed ORCID: 0000-0002-6404-7444

OpenAlex ID: A5085682191

CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response

2017 · Shilpak Chatterjee, Anusara Daenthanasanmak, et al. · Cell Metabolism · 267

PDF

Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation

2016 · Hung D. Nguyen, Shilpak Chatterjee, et al. · Journal of Clinical Investigation · 128

PDF

Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice

2018 · Anusara Daenthanasanmak, Supinya Iamsawat, et al. · Blood · 78

PDF

Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation

2018 · Brian C. Betts, David Bastian, et al. · Proceedings of the National Academy of Sciences · 73

Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response

2018 · Shilpak Chatterjee, Paramita Chakraborty, et al. · Clinical Cancer Research · 64

Ceramide synthesis regulates T cell activity and GVHD development

2017 · M. Hanief Sofi, Jessica Heinrichs, et al. · JCI Insight · 60

PDF

EGR1-mediated metabolic reprogramming to oxidative phosphorylation contributes to ibrutinib resistance in B-cell lymphoma

2023 · Yunxia Liu, Shuichi Kimpara, et al. · Blood · 55

PDF

Dendritic Cell–Mediated Immune Humanization of Mice: Implications for Allogeneic and Xenogeneic Stem Cell Transplantation

2014 · Gustavo Salguero, Anusara Daenthanasanmak, et al. · The Journal of Immunology · 48

Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma

2021 · Takashi Ishio, Sarvesh Kumar, et al. · Blood · 42

PDF

Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease

2019 · M. Hanief Sofi, Yongxia Wu, et al. · Journal of Clinical Investigation · 42

PDF

A very long-acting IL-15: implications for the immunotherapy of cancer

2022 · John A Hangasky, Wei Chen, et al. · Journal for ImmunoTherapy of Cancer · 41

PDF

PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity

2018 · Anusara Daenthanasanmak, Yongxia Wu, et al. · Journal of Clinical Investigation · 41

PDF

Complement C3a and C5a receptors promote GVHD by suppressing mitophagy in recipient dendritic cells

2018 · Hung Nguyen, Sandeepkumar Kuril, et al. · JCI Insight · 38

Stabilization of Foxp3 by Targeting JAK2 Enhances Efficacy of CD8 Induced Regulatory T Cells in the Prevention of Graft-versus-Host Disease

2018 · Supinya Iamsawat, Anusara Daenthanasanmak, et al. · The Journal of Immunology · 33

Vitamin C stabilizes CD8+ iTregs and enhances their therapeutic potential in controlling murine GVHD and leukemia relapse

2019 · Supinya Iamsawat, Linlu Tian, et al. · Blood Advances · 27

Engineered dendritic cells from cord blood and adult blood accelerate effector T cell immune reconstitution against HCMV

2015 · Anusara Daenthanasanmak, Gustavo Salguero, et al. · Molecular Therapy — Methods & Clinical Development · 24

PDF

Inducible T-Cell Co-Stimulator Impacts Chronic Graft-Versus-Host Disease by Regulating Both Pathogenic and Regulatory T Cells

2018 · Mengmeng Zhang, Yongxia Wu, et al. · Frontiers in Immunology · 22

PDF

Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo

2012 · Anusara Daenthanasanmak, Gustavo Salguero, et al. · Vaccine · 20

Generation of lentivirus-induced dendritic cells under GMP-compliant conditions for adaptive immune reconstitution against cytomegalovirus after stem cell transplantation

2015 · Bala Sai Sundarasetty, Stephan Kloess, et al. · Journal of Translational Medicine · 17

PDF

Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma

2022 · Anusara Daenthanasanmak, Richard N. Bamford, et al. · Blood Advances · 15

EGR1 Addiction in Diffuse Large B-cell Lymphoma

2021 · Shuichi Kimpara, Li Lu, et al. · Molecular Cancer Research · 15

PDF

Enhanced efficacy of JAK1 inhibitor with mTORC1/C2 targeting in smoldering/chronic adult T cell leukemia

2020 · Anusara Daenthanasanmak, Yuquan Lin, et al. · Translational Oncology · 14

PDF

Targeting the Complement Alternative Pathway Permits Graft Versus Leukemia Activity while Preventing Graft Versus Host Disease

2020 · Hung Nguyen, Ali Alawieh, et al. · Clinical Cancer Research · 11

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

2016 · Andreas Lundqvist, Vincent van Hoef, et al. · Journal for ImmunoTherapy of Cancer · 11

PDF

Growing Bacteria Shed Elicitors of Drosophila Humoral Immunity

2011 · Jenny Karlsson, Sandra Oldenvi, et al. · Journal of Innate Immunity · 9

Works count: 56

Citation count: 1,204

H-index: 18

I10-index: 24